Efbemalenograstim alfa
id:
efbemalenograstim-alfa-181-857462
title:
Efbemalenograstim alfa
text:
Efbemalenograstim alfa, sold under the brand name Ryzneuta, is a medication used to decrease the incidence of infection in chemotherapy-induced neutropenia. It is a leukocyte growth factor. It is given by subcutaneous injection. The most common side effects of efbemalenograstim alfa are nausea, anemia, and thrombocytopenia. Efbemalenograstim alfa is an immunostimulant/colony stimulating factor that belongs to the class of hematopoietic growth factors which increase the production and differentia
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Efbemalenograstim_alfa
date created:
2023-11-17T20:43:05Z
date modified:
2024-09-05T15:37:53Z
main entity:
{"identifier":"Q123499549","url":"https://www.wikidata.org/entity/Q123499549"}
image:
fields total:
13
integrity:
15